CASI Pharmaceuticals, Inc.
(NASDAQ : CASI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.59%182.510.7%$1411.48m
MRKMerck & Co., Inc. 1.39%93.280.7%$1241.52m
PFEPfizer Inc. 3.21%51.700.9%$1234.19m
BMYBristol-Myers Squibb Co. 1.67%78.991.0%$1137.41m
LLYEli Lilly & Co. 4.15%325.691.1%$1136.04m
ABBVAbbVie, Inc. 2.07%152.551.9%$1019.26m
AZNAstraZeneca Plc 3.80%66.901.0%$452.09m
SGENSeagen Inc. 3.06%179.335.7%$326.01m
GSKGSK Plc 2.20%43.690.2%$297.44m
TPTXTurning Point Therapeutics, Inc. 0.03%75.170.0%$291.93m
SIGASIGA Technologies, Inc. -0.46%13.040.0%$219.68m
MRTXMirati Therapeutics, Inc. 3.45%68.161.6%$199.41m
HZNPHorizon Therapeutics Plc 2.68%85.135.4%$182.59m
NVSNovartis AG 3.62%84.820.2%$167.75m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.14%144.000.0%$147.86m

Company Profile

CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.